Literature DB >> 21249330

[Clinical evaluation of subarachnoid hemorrhaging].

S Walter1.   

Abstract

The classical symptoms of subarachnoid hemorrhaging are acute severe headache, stiff neck, confusion and often vegetative symptoms up to severe cardiac functional disorders. The extent of confusion is variable and correlates with the severity of the disease. Clinical signs are often loss of feeling in cranial nerves which can be indicative not only of the localization of the aneurysm but also of increased brain pressure. Terson's syndrome of vitreous hemorrhaging is indicative of a poor prognosis.Neurological focal symptoms are indicative of intraparenchymal hemorrhage but accompanying cramp attacks often occur independently. Subarachnoid hemorrhaging can present as a transient neurological symptomatic without relevant headache particularly in elderly patients. Despite substantial research activity the prognosis remains as before dependent on the initial clinical symptomatic, as previously described by Hunt and Hess in 1968. Assessment of the severity is nowadays often made in combination with the Glasgow coma scale (GCS).

Entities:  

Mesh:

Year:  2011        PMID: 21249330     DOI: 10.1007/s00117-010-2048-z

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  19 in total

Review 1.  A review of delayed ischemic neurologic deficit following aneurysmal subarachnoid hemorrhage: historical overview, current treatment, and pathophysiology.

Authors:  Yahia Z Al-Tamimi; Nicolas M Orsi; Audrey C Quinn; Shervanthi Homer-Vanniasinkam; Stuart A Ross
Journal:  World Neurosurg       Date:  2010-06       Impact factor: 2.104

2.  Prediction of 60 day case-fatality after aneurysmal subarachnoid haemorrhage: results from the International Subarachnoid Aneurysm Trial (ISAT).

Authors:  R Risselada; H F Lingsma; A Bauer-Mehren; C M Friedrich; A J Molyneux; R S C Kerr; J Yarnold; M Sneade; E W Steyerberg; M C J M Sturkenboom
Journal:  Eur J Epidemiol       Date:  2010-02-14       Impact factor: 8.082

Review 3.  Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage.

Authors:  Timour Al-Khindi; R Loch Macdonald; Tom A Schweizer
Journal:  Stroke       Date:  2010-07-01       Impact factor: 7.914

4.  Surgical risk as related to time of intervention in the repair of intracranial aneurysms.

Authors:  W E Hunt; R M Hess
Journal:  J Neurosurg       Date:  1968-01       Impact factor: 5.115

Review 5.  Time trends in outcome of subarachnoid hemorrhage: Population-based study and systematic review.

Authors:  C E Lovelock; G J E Rinkel; P M Rothwell
Journal:  Neurology       Date:  2010-04-07       Impact factor: 9.910

6.  Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage.

Authors:  Andrew M Naidech; Kurt T Kreiter; Nazli Janjua; Noeleen D Ostapkovich; Augusto Parra; Christopher Commichau; Brian-Fred M Fitzsimmons; E Sander Connolly; Stephan A Mayer
Journal:  Circulation       Date:  2005-11-01       Impact factor: 29.690

7.  Level of consciousness and age as prognostic factors in aneurysmal SAH.

Authors:  R Deruty; I Pelissou-Guyotat; C Mottolese; D Amat; L Bognar
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

8.  Crescendo transient Aura attacks: a transient ischemic attack mimic caused by focal subarachnoid hemorrhage.

Authors:  Aaron Izenberg; Richard I Aviv; Bart M Demaerschalk; David W Dodick; Julia Hopyan; Sandra E Black; David J Gladstone
Journal:  Stroke       Date:  2009-11-05       Impact factor: 7.914

9.  Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning.

Authors:  C M Fisher; J P Kistler; J M Davis
Journal:  Neurosurgery       Date:  1980-01       Impact factor: 4.654

10.  Subarachnoid blood on CT and memory dysfunctions in aneurysmal subarachnoid hemorrhage.

Authors:  C Larsson; A Forssell; J Rönnberg; M Lindberg; L G Nilsson; H Fodstad
Journal:  Acta Neurol Scand       Date:  1994-11       Impact factor: 3.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.